Bernard Prendergast and Philippe Généreux detail the EARLY TAVR trial design and outcomes.

Juan Granada and Pierre Elias discuss how AI is an essential tool for improving screening access and increasing early diagnosis of valvular heart disease.

Juan Granada and Brian Lindman share insights on tools and data that can be used to achieve earlier diagnosis and intervention in valvular heart disease.

Sammy Elmariah and David Playford discuss the ways technology and AI can be used to assist in better treatment and diagnosis of severe aortic stenosis. 

Martha Gulati and Kathyn Berlacher talk about tangible ways to improve women's cardiovascular care, including nontraditional, patient-centered solutions.

Clyde Yancy, Suzanne Baron, and Bruce Rutkin discuss ways to address the undertreatment of CVD in women at the patient, provider, structural, and societal levels.

Clyde Yancy talks to Sharonne Hayes and Robert Harrington about the barriers that have historically hindered diagnosing heart disease in women, including sex differences in disease presentation and outdated biases.

Clyde Yancy talks to Priya Freaney and Nisha Parikh about the landscape of cardiovascular care for women and how it can be improved, both for patients and women training to be cardiologists.

Clyde Yancy, Roxana Mehran, and Howard Herrmann discuss strategies for increasing clinical trial enrollment among women, including targeting disease phenotypes and sex-specific trials.

Sreek Vemulapalli and Roseann White explain the statistical challenges that can arise while collecting longer-term follow-up data during clinical trials.